Peer-Reviewed Study Calls For “IMMEDIATE WITHDRAWAL of mRNA COVID Vaccines For Use in Pregnancy

After re-analyzing a study performed by Centers for Disease Control and Prevention (CDC) researchers, a peer-reviewed study has called for the “immediate withdrawal of mRNA COVID vaccines for pregnant women, those breastfeeding, those of childbearing age and children after their shocking study reveals stunning results of pregnant mRNA vaccinated women: 92% of the women had a spontaneous miscarriage in the first 13 weeks…while 81.9% of women who received the mRNA COVID vaccine had a spontaneous miscarriage in the first 20 weeks.

The study warns that the conclusions of the Shimabukuro study that support the use of the mRNA vaccine in early pregnancy, which has now been hastily incorporated into many international guidelines for vaccine use, ignores the horrors of thalidomide, a drug commonly taken by pregnant women in the late ’50s and early ’60s to prevent nausea during pregnancy. Thalidomide ended up causing severe birth defects in thousands of children, including scores of children being born without limbs

Here is a portion of their study:

From the Science, Public Health Policy and the Law report:

The use of mRNA vaccines in pregnancy is now generally considered safe for protection against COVID-19 in countries such as New Zealand, USA, and Australia. However, the influential CDC- sponsored article by Shimabukuro et al. (2021) used to support this idea, on closer inspection, provides little assurance, particularly for those exposed in early pregnancy. The study presents falsely reassuring statistics related to the risk of spontaneous abortion in early pregnancy, since the majority of women in the calculation were exposed to the mRNA product after the outcome period was defined (20 weeks’ gestation).

In this article, we draw attention to these errors and recalculate the risk of this outcome based on the cohort that was exposed to the vaccine before 20 weeks’ gestation. Our re-analysis indicates a cumulative incidence of spontaneous abortion 7 to 8 times higher than the original authors’ results

(p < 0.001) and the typical average for pregnancy loss during this time period. In light of these findings, key policy decisions have been made using unreliable and questionable data. We conclude that the claims made using these data on the safety of exposure of women in early pregnancy to mRNA-based vaccines to prevent COVID-19 are unwarranted and recommend that those policy decisions be revisited.

The study indicates that at least 81.9% (≥ 104/127) experienced spontaneous abortion following mRNA exposure before 20 weeks, and 92.3% (96/104) of spontaneous abortions occurred before 13 weeks’ gestation.